One title in particular jumped out at me when I researching for my blog this week: Advice from a VC to startups: Speak no evil about the FDA. What?!? OK, so perhaps I have been trashing the FDA a bit lately, but not without cause… Right? Here’s a bit of an excerpt from the article:
After a short complaint about the FDA coming from another panelist — John Ryan of Onset Ventures — Juliet Bakker, founder and managing director of Longitude Capital, said that her advice to portfolio companies is to be always be respectful of the FDA.
“After all, they are here to protect us,” she said.
Bakker added that on many occasions companies and regulatory consultants don’t ” bother to answer the questions that the FDA has asked” or give the answers that they want to give. That, she said, creates delays. And delays are anathema to the venture capital and startup community eager to see a return on investment.
Are we too hard on the FDA? Should we be more sympathetic to their cause? What do you think?